Search

everythinglearnresearchcommunity

for

Search:↓

Hair growth dysfunction involves various conditions with limited treatment options.

Botox increased hair count in men with baldness and might work by improving scalp blood flow.

Lichen planopilaris can be accurately diagnosed and effectively treated.

Antimicrobial therapy can help manage Folliculitis Decalvans.

Some breast cancer patients developed permanent hair loss after chemotherapy and hormonal therapy, showing patterns similar to common baldness and alopecia areata.

Diagnosing hair loss disorders needs clinical, dermoscopic, and histological differences, and checking menstrual cycle, weight changes, drug therapy, and nail changes.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

Permanent hair loss from cicatricial alopecia is treated by reducing inflammation and managing symptoms, but regrowth in scarred areas is unlikely.

Nonscarring alopecia has higher hair density than scarring alopecia, and hair density can help diagnose the type of alopecia.

No treatment has been proven to effectively stop hair loss or regrow hair in Frontal Fibrosing Alopecia, and more research is needed.

Asian patients with Frontal Fibrosing Alopecia often lose eyebrow hair and respond well to combined antiandrogen or antimalarial and topical treatments.

Frontal fibrosing alopecia in families shows similar signs to individual cases and may have a genetic link.

The BASP classification is effective for diagnosing pattern hair loss in Indian men and women.

Injections with 0.5% minoxidil effectively treat female hair loss, increasing hair density and thickness.

Female pattern hair loss involves thinning hair on crown and frontal scalp, diagnosed by hair ratio, and treated with minoxidil, antiandrogens, or hair transplantation.

Early diagnosis and targeted anti-inflammatory treatments can improve outcomes in androgenetic alopecia with perifollicular inflammation and fibrosis.

The current understanding of frontal fibrosing alopecia involves immune, genetic, hormonal factors, and possibly environmental triggers, but more research is needed for effective treatments.

Women with lichen planopilaris often have thyroid disease, depression, anxiety, and may respond to treatment with slowed disease progression.

Clinical signs don't match inflammation levels in lichen planopilaris and frontal fibrosing alopecia.

Both treatments help hair regrowth, but Botulinum Toxin-A has fewer side effects.

Half of people with Alopecia Areata may see hair regrowth within a year without treatment, but recovery is unpredictable.

Finasteride and minoxidil are effective for hair loss, but continued research is needed for better treatments.

Alopecia areata is an autoimmune condition causing hair loss, influenced by genetics, stress, and diet, and may be prevented by a high soy oil diet.

The modified Ferriman-Gallwey method is a useful tool for diagnosing hirsutism.

Dermoscopy is a useful tool for identifying features of skin conditions, but more research is needed to define its role in dermatology.

The document concludes that understanding hair follicle biology can lead to better hair loss treatments.

Some treatments can help with a hair loss condition called alopecia areata, but none ensure lasting results; choices depend on the person, with JAK inhibitors showing promise for severe cases.

A substance called DKK-1 increases in balding areas and causes hair cells to die when exposed to DHT.

The conclusion is that accurate diagnosis of different types of hair loss requires good teamwork between skin doctors and lab experts.

Estrogens significantly influence hair growth by interacting with receptors in hair follicles and may help regulate the hair growth cycle.